2023
Analysis of brain edema in RHAPSODY
Schleicher R, Vorasayan P, McCabe M, Bevers M, Davis T, Griffin J, Hinduja A, Jadhav A, Lee J, Sawyer R, Zlokovic B, Sheth K, Fedler J, Lyden P, Kimberly W, Investigators O. Analysis of brain edema in RHAPSODY. International Journal Of Stroke 2023, 19: 68-75. PMID: 37382409, PMCID: PMC10789908, DOI: 10.1177/17474930231187268.Peer-Reviewed Original ResearchConceptsNet water uptakeMidline shiftCerebral edemaMarkers of edemaImaging markerClinical outcomesBrain magnetic resonance imaging (MRI) scansMass effectMagnetic resonance imaging (MRI) scansSupratentorial ischemic lesionsAcute ischemic strokeBaseline stroke volumeProtein C treatmentResonance imaging scansCerebrospinal fluid volumeTime courseIschemic strokeBaseline visitIschemic lesionsTrial cohortBrain edemaTreatment armsSecondary complicationsFuture trialsImaging scans
2019
Cerebral Edema and Intracranial Pressure in the Neurocritical Care Unit
Ghosal S, Sheth K. Cerebral Edema and Intracranial Pressure in the Neurocritical Care Unit. 2019, 19-27. DOI: 10.1017/9781107587908.003.Peer-Reviewed Original ResearchNeurosurgical patientsNeurocritical care providersCritical care conditionsNeurocritical care unitCritical care physiciansCerebral edemaSurgical ICUIll patientsCare physiciansCare unitICU settingIntracranial pressureCare conditionsCare providersPatientsPhysiciansThorough guideTreatmentSignificant numberDay managementICUEdemaNeurologistsManagementClear summary
2017
Intracerebral Hemorrhage
Stevenson D, Sheth K. Intracerebral Hemorrhage. 2017, 75-91. DOI: 10.1007/978-3-319-48669-7_5.Peer-Reviewed Original ResearchSecondary intracerebral hemorrhageIntracerebral hemorrhageNontraumatic intracerebral hemorrhageIschemic strokeChronic small vessel diseasePrimary intracerebral hemorrhageSmall vessel diseaseCritical care settingHemorrhagic transformationCerebral edemaBlood pressureThorough historyBlood glucoseBrain parenchymaPhysical examVascular malformationsDistinct pathophysiologyIntracranial pressureAnatomical anomaliesCare settingsHemorrhageStrokeFinal manifestationEdemaPatients
2016
Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial
Sheth KN, Elm JJ, Molyneaux BJ, Hinson H, Beslow LA, Sze GK, Ostwaldt AC, del Zoppo GJ, Simard JM, Jacobson S, Kimberly WT. Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial. The Lancet Neurology 2016, 15: 1160-1169. PMID: 27567243, DOI: 10.1016/s1474-4422(16)30196-x.Peer-Reviewed Original ResearchConceptsPlacebo-controlled phase 2 trialIntravenous glyburideLarge hemispheric infarctionPhase 2 trialGlyburide groupHemispheric infarctionDecompressive craniectomyPlacebo groupBrain swellingModified Rankin Scale scoreProtocol study populationWeb-based randomisationComposite primary outcomePrimary efficacy outcomeSerious adverse eventsProportion of patientsRankin Scale scoreBolus intravenous injectionLarge hemispheric strokePotential clinical benefitEfficacy outcomesStudy drugAdverse eventsCardiac eventsCerebral edema
2013
Glyburide is Associated with Attenuated Vasogenic Edema in Stroke Patients
Kimberly WT, Battey TW, Pham L, Wu O, Yoo AJ, Furie KL, Singhal AB, Elm JJ, Stern BJ, Sheth KN. Glyburide is Associated with Attenuated Vasogenic Edema in Stroke Patients. Neurocritical Care 2013, 20: 193-201. PMID: 24072459, PMCID: PMC5198519, DOI: 10.1007/s12028-013-9917-z.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedBiomarkersBrain EdemaBrain IschemiaCase-Control StudiesClinical Trials as TopicCohort StudiesDouble-Blind MethodFemaleGlyburideHumansHypoglycemic AgentsMagnetic Resonance ImagingMaleMatrix Metalloproteinase 9Middle AgedPilot ProjectsRandom AllocationRetrospective StudiesStrokeTreatment OutcomeConceptsVasogenic edemaIschemic strokeStroke patientsMagnetic resonance imagesMatrix metalloproteinase-9 plasma levelsSerial brain magnetic resonance imagesTransient receptor potential cation channelM member 4Secondary neurological deteriorationPlacebo-controlled trialMMP-9 levelsLarge hemispheric strokeBrain magnetic resonance imagesPreclinical rodent modelsSulfonylurea receptor 1Case-control designBrain swellingCerebral edemaNeurological deteriorationHuman strokeSerious complicationsGlyburide treatmentHemispheric strokeBlood biomarkersBlood markers